The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriersK.A. Metcalfe, H.T. Lynch, P. Ghadirian, N. Tung, I.A. Olivotto, W.D. Foulkes, E. Warner, O. Olopade, A. Eisen, B. Weber, et al. Gynecol Oncol 2005;96:222–26

Autor:	Mark E. Robson
Rok vydání:	2005
Předmět:	Gynecology Oncology medicine.medical_specialty endocrine system diseases business.industry medicine.disease female genital diseases and pregnancy complications BRCA2 Mutation Breast cancer Internal medicine medicine skin and connective tissue diseases Ovarian cancer business
Zdroj:	The Women's Oncology Review. 5:163-164
ISSN:	1473-3412 1473-3404
DOI:	10.3109/14733400500178592
Popis:	ObjectiveTo generate estimates of the risk of ovarian cancer after a primary diagnosis of breast cancer among women with a BRCA1 or BRCA2 mutation and to identify host and treatment-related factors that might modify risk.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e0901b551dfff477efa8603a1ec8924b https://doi.org/10.3109/14733400500178592 Zobrazit plný text záznamu Plný text ve formátu PDF